1.31
price down icon6.76%   -0.095
 
loading
前日終値:
$1.405
開ける:
$1.41
24時間の取引高:
368.86K
Relative Volume:
0.14
時価総額:
$42.83M
収益:
-
当期純損益:
$-87.23M
株価収益率:
-0.4411
EPS:
-2.97
ネットキャッシュフロー:
$-82.77M
1週間 パフォーマンス:
-13.25%
1か月 パフォーマンス:
-58.41%
6か月 パフォーマンス:
-85.26%
1年 パフォーマンス:
-90.95%
1日の値動き範囲:
Value
$1.27
$1.42
1週間の範囲:
Value
$1.27
$1.64
52週間の値動き範囲:
Value
$1.16
$19.30

Pepgen Inc Stock (PEPG) Company Profile

Name
名前
Pepgen Inc
Name
セクター
Healthcare (1165)
Name
電話
703-456-8000
Name
住所
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Name
職員
81
Name
Twitter
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
PEPG's Discussions on Twitter

PEPG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PEPG
Pepgen Inc
1.31 42.83M 0 -87.23M -82.77M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Pepgen Inc Stock (PEPG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-16 ダウングレード BofA Securities Neutral → Underperform
2024-07-31 ダウングレード BofA Securities Buy → Neutral
2022-12-21 開始されました H.C. Wainwright Buy

Pepgen Inc (PEPG) 最新ニュース

pulisher
Apr 01, 2025

PepGen Announces Appointment of Two New Directors to its Board - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

PepGen Inc. Expands Board with New Appointments - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

PepGen names two new directors to board - TipRanks

Mar 31, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

PepGen CMO Mellion resigns, effective April 4 - Investing.com

Mar 28, 2025
pulisher
Mar 26, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen IncPEPG - Bluefield Daily Telegraph

Mar 26, 2025
pulisher
Mar 18, 2025

PEPG ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of PepGen Inc. Shareholders Who Lost Money - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 10, 2025

PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - Business Wire

Mar 10, 2025
pulisher
Mar 10, 2025

PepGen Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsPEPG - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 05, 2025

PepGen Inc. Faces Clinical Trial Challenges and Competitive Pressures Leading to Sell Rating - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

What Do Analysts Think Will Happen To PepGen Inc (NASDAQ: PEPG) - Stocks Register

Mar 05, 2025
pulisher
Mar 04, 2025

PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen To Voluntarily Pause Mid-Stage Duchenne Muscular Dystrophy Study, Stock Falls - Benzinga

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Boston biotech's stock drops after Duchenne trial pause - The Business Journals

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to pause CONNECT2-EDO51 study - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen slumps after pausing mid-stage study of Duchenne drug - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen pauses phase 2 DMD study to review earlier trial data - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD -March 04, 2025 at 08:18 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen stock slides after trial pause (PEPG:NASDAQ) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 04, 2025

Pepgen Announces Update To Phase 2 Connect2-Edo51 Study In Patients With DMD - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

PepGen to Participate in Upcoming Investor Conferences - Business Wire

Mar 04, 2025
pulisher
Mar 04, 2025

AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - Asianet Newsable

Mar 04, 2025
pulisher
Mar 03, 2025

PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz? - Asianet Newsable

Mar 03, 2025
pulisher
Mar 03, 2025

PepGen (PEPG) to Release Quarterly Earnings on Wednesday - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Q1 Earnings Estimate for PepGen Issued By HC Wainwright - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Q1 Earnings Forecast for PepGen Issued By Leerink Partnrs - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

PepGen Inc. (NASDAQ:PEPG) Stock Analysis: Earnings Estimates, Analyst Ratings, and Market Performance - HPBL

Feb 28, 2025
pulisher
Feb 28, 2025

Wedbush Weighs in on PepGen’s Q1 Earnings (NASDAQ:PEPG) - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

What is HC Wainwright’s Estimate for PepGen FY2025 Earnings? - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

PepGen (PEPG) Shares Rally In Extended Session - Stocks Telegraph

Feb 28, 2025
pulisher
Feb 27, 2025

HC Wainwright Reiterates Buy Rating for PepGen (NASDAQ:PEPG) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Stock market news: Binah Capital Group +184.15%, PepGen +35.25% among top gainers during midday trading - Business Upturn

Feb 27, 2025
pulisher
Feb 27, 2025

Promising Prospects for PepGen Inc.: Buy Rating Affirmed Amid Positive DM1 Treatment Developments - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

What is HC Wainwright’s Estimate for PepGen Q1 Earnings? - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

PepGen CFO Noel Donnelly sells $2,565 in stock By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen general counsel DeLena sells $2,405 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen general counsel DeLena sells $2,405 in stock By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen CFO Noel Donnelly sells $2,565 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

PepGen reports positive initial data from Phase I DM1 therapy trial - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

Promising Biotech Stocks Worth Watching – February 24th - Defense World

Feb 26, 2025
pulisher
Feb 25, 2025

PepGen Inc. Reports Positive Trial Results and Financials - TipRanks

Feb 25, 2025

Pepgen Inc (PEPG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):